Why is Emcure Pharma falling/rising?

As of 09-Jul, Emcure Pharmaceuticals Ltd is experiencing a price increase, currently at 1,262.30, reflecting a rise of 19.3 or 1.55%. Today's price summary indicates that the stock has outperformed its sector by 1.35% and has shown a trend reversal after three consecutive days of decline. It opened with a gain of 3.78% and reached an intraday high of Rs 1289.95. However, the stock's performance over the past week and month has been negative, with declines of 0.53% and 4.66%, respectively. The company has demonstrated high management efficiency with a return on capital employed (ROCE) of 20.07% and has reported positive results for the last three consecutive quarters, which may contribute to the recent uptick in stock price. Conversely, concerns about long-term growth persist, as the operating profit has only grown at an annual rate of 8.80% over the last five years.
Broader market context shows that while Emcure Pharmaceuticals has seen a short-term rise, its year-to-date performance is significantly lagging behind the benchmark Sensex, which has gained 6.91% during the same period. The stock's recent gains may be attributed to a temporary recovery after a series of declines, but its overall performance remains weak compared to the market. The falling investor participation, with a significant drop in delivery volume, suggests caution among investors, which could impact future price movements. Despite the positive quarterly results, the stock's expensive valuation and poor long-term growth prospects may continue to weigh on investor sentiment.